In light of the strong desire to shorten timelines and lower cost for biologics such as monoclonals specially biosimilars, and address surging demand for complex proteins such as bispecific antibodies ...
Overcoming common challenges with today’s biologics, such as developing devices for high-concentration subcutaneous ...
DUBLIN--(BUSINESS WIRE)--The "Biologics Contract Manufacturing Market Industry Trends and Global Forecasts to 2035, by Type of Service Offered, Type of Biologic Manufactured, Type of Expression System ...
The biopharmaceutical industry is expanding rapidly, driven by an increasing demand for complex biomedicines. Today, manufacturing biomolecules presents unique challenges, like cost pressure and ...
The program leverages Just - Evotec Biologics' advanced biomanufacturing platform to deliver high-quality, scalable, cost-efficient production through significantly higher yieldsManufacturing process ...
Before the advent of biologics, commercialization of a therapeutic relied on successfully scaling up to meet market demand. This scaling-up strategy expanded biomanufacturing capacity by upsizing the ...
Monoclonal antibodies (mAbs) have revolutionized modern medicine, offering precision therapies for cancer, autoimmune disorders, infectious diseases, and numerous other advantages. The global mAb ...
REDWOOD CITY, Calif.--(BUSINESS WIRE)-- C3 AI (NYSE: AI), the Enterprise AI application software company, today announced that Genentech, the medical biotechnology company, has selected C3 AI ...
Dublin, March 02, 2026 (GLOBE NEWSWIRE) -- The "Continuous Manufacturing Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Type of Drug Molecule, Stage of Bioprocessing, Type ...
WILMINGTON, Del., March 12, 2026 /PRNewswire/ -- Earendil Labs, a global leader in AI-driven research and development of next-generation biologics therapeutics, and WuXi Biologics (2269.HK), a global ...
Yonhap News Agency on MSN
Lotte Biologics signs CDMO deal with US firm for antibody drug substance
Lotte Biologics Co., the biotech arm of Lotte Group, said Wednesday it has signed a contract with a U.S.-based oncology ...
WuXi Biologics ('WuXi Bio') (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results